PETALUMA, Calif., May 9, 2012 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS), a commercial healthcare company that designs, produces and markets innovative, safe and effective healthcare products in multiple markets, announced the company would be exhibiting its Microcyn®-based products at Columbia University's 10th Annual Innovations in Complex Vascular & Endovascular Interventions in New York City, May 10-11, 2012. The two-day educational conference for clinicians will focus on complex arterial and venous vascular procedures, including management options for non-healing wounds and advances in podiatric wound management.
